Deciphering the coupling mechanisms between post-harvest precursor shaping and roasting thermochemistry is pivotal for precise coffee flavor modulation. This study aimed to investigate the regulation mechanisms of in vitro biomimetic fermentation (BF) on the precursor-roasting reaction network. Integrated multi-omics characterization and sensory evaluation reveal that the BF protocol achieves targeted substrate enrichment, notably amplifying free amino acids—particularly leucine and phenylalanine—by 1.89-fold while accumulating lactate and succinate buffering salt systems. This reconfiguration constructs a matrix with superior thermal buffering capacity (ΔpH 0.17), which optimizes the thermal reaction kinetic window during roasting. Consequently, BF drives a 3.08-fold surge in esterification flux, significantly increasing the abundance of key fruity markers such as ethyl acetate and ethyl isovalerate. It also enhances the diversity of Maillard products, specifically elevating nutty-associated alkylpyrazines (e.g., 2,3,5-trimethylpyrazine). Concurrently, BF improves the thermal stability of bioactive compounds, including 5-caffeoylquinic acid (5-CQA) and trigonelline. Multi-scale molecular dynamics and quantum chemical calculations elucidate that BF-derived organic acid–salt complexes exert a ‘pseudo-catalytic effect,’ lowering activation free energy barriers for critical aroma-generating reactions by approximately 8.5 kcal/mol. This study demonstrates high sensory predictability (predictive model R2 = 0.98) and provides a quantitative theoretical framework to advance coffee processing from empirical observation to rational flavor design.
Equol is a metabolite of daidzein and has a higher biological activity than daidzein. Equol, combined with estrogen receptors, can reduce the incidence of diseases such as cardiovascular disease, osteoporosis, and breast cancer; more effectively alleviate the symptoms of perimenopausal syndrome; and improve age-related decline of the uterus and ovaries. Research has shown that food composition can greatly affect the formation of equol in the intestinal tract. In the intestines, the content of nonstarch polysaccharides that can stimulate fermentation is high, thereby allowing intestinal bacteria to quickly and completely transform the daidzein into equol. This study used Sprague Dawley (SD) rats as a model, where menopause was established through direct intragastric administration of formistan. In the 6-week-long experiment, intragastric administration of RS while feeding bean pulp reduced the body weight of postmenopausal rats, reduced the efficiency of feed utilization of rats, and increased the weight of organs such as the uterus and ovaries. Routine blood indexes showed that no adverse reactions were produced by intragastric administration of RS. 16s rDNA sequencing further verified Lactobacillus and Clostridium XIVa, as the bacteria that converted daidzein into equol.
Marigold (Tagetes erecta L.) residue, a by-product of industrial lutein extraction, is rich in carotenoids and polyphenols, offering potential as a poultry feed additive. This study employed Lactobacillus plantarum for solid-state fermentation of marigold meal and evaluated dietary inclusion (5 % or 10 %) in broilers for 42 days. Fermented marigold meal had no significant effects on growth performance or basic meat quality (pH, color, water-holding capacity) but improved breast muscle composition by increasing non-essential amino acids (e.g., glutamate, GABA), n-3 PUFAs, and PUFA/SFA ratio, while reducing MUFAs. 16S rRNA sequencing revealed enrichment of beneficial bacteria (Parabacteroides, Lactobacillus) and higher butyric acid levels. GC–MS identified 171 volatile compounds, with elevated key aroma compounds (e.g., 2(3H)-furanone, Geranylacetone) in marigold-fed groups, linked to altered microbiota. Fermented marigold meal enhances meat nutrition and flavor through gut microbiota-mediated pathways, providing a sustainable approach for high-value utilization of agricultural by-products.
In this manuscript, we report the successful purification of two polysaccharide fractions (F1 and F2) from Cinnamomum cassia (C. cassia). Their chemical composition analysis revealed carbohydrates (54.8–61.1%), sulfates (8.1–9.5%), proteins (4.8–8.0%), and uronic acids (3.7–3.9%), with molecular weights ranging from 46.1 to 2919.1 kDa. Methylation analysis indicated that the highly active F2 fraction possesses a main chain of (1 → 4)-linked glucose, with minor side chains of (1 → 3)- and (1 → 5)-linked arabinose or (1 → 6)-linked glucose, and terminal glucose/arabinose residues. In vitro experiments demonstrated that F2 significantly enhanced nitric oxide and cytokine (TNF-α, IL-1β, IL-6, IL-10) production in RAW264.7 macrophages through activation of NF-κB and MAPK signaling pathways, exhibiting stronger immunomodulatory activity than F1. These results provide evidence that C. cassia polysaccharides, particularly F2, possess promising potential as natural immunostimulants for functional food or therapeutic applications.
Obesity, a major risk factor for cardiometabolic diseases, arises from chronic energy imbalance and ectopic lipid deposition. This study investigated the anti-obesity potential of Coral dealbatus crude polysaccharides (CDP), a previously uncharacterized bioactive fraction from a hybrid vegetable cultivar developed by the Chinese Academy of Agricultural Sciences. CDP, obtained via hydroalcoholic extraction, was structurally characterized as amorphous with heterogeneous molecular weights (87,813 Da, 4158 Da, and 728 Da) and glucose-dominant monosaccharide composition (FT-IR, XRD, and HPLC). In a high-fat diet (HFD)-induced murine obesity model, oral CDP administration significantly attenuated body weight gain (p < 0.05) and reduced ectopic lipid deposition. Histopathological analysis confirmed CDP’s efficacy in ameliorating hepatic steatosis, evidenced by diminished lipid droplet accumulation. Furthermore, CDP reversed HFD-induced gut microbiota dysbiosis, modulating beneficial bacterial taxa. These findings demonstrate CDP’s therapeutic potential against diet-induced metabolic disorders, likely mediated through lipid metabolism regulation and intestinal microbiota modulation, supporting its development as a novel functional food ingredient for dietary intervention.